Back to Search
Start Over
An orthotopic syngeneic mouse model of bortezomib‐resistant multiple myeloma.
An orthotopic syngeneic mouse model of bortezomib‐resistant multiple myeloma.
- Source :
- British Journal of Haematology; Feb2024, Vol. 204 Issue 2, p566-570, 5p
- Publication Year :
- 2024
-
Abstract
- Summary: While bortezomib has significant benefits in multiple myeloma (MM) therapy, the disease remains incurable due to the invariable development of bortezomib resistance. This emphasises the need for advanced models for preclinical evaluation of new therapeutic approaches for bortezomib‐resistant MM. Here, we describe the development of an orthotopic syngeneic bortezomib‐resistant MM mouse model based on the most well‐characterised syngeneic MM mouse model derived from spontaneous MM‐forming C57BL/KaLwRij mice. Using bortezomib‐resistant 5TGM1 cells, we report and characterise a robust syngeneic mouse model of bortezomib‐resistant MM that is well suited to the evaluation of new therapeutic approaches for proteasome inhibitor‐resistant MM. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 00071048
- Volume :
- 204
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- British Journal of Haematology
- Publication Type :
- Academic Journal
- Accession number :
- 175303685
- Full Text :
- https://doi.org/10.1111/bjh.19240